On December 17, 2024, the FDA published five (5) warning letters previously issued to makers of knockoff GLP-1 drugs
Nearly 2 in 5 respondents (39%) expressed confidence in GLP-1s' long-term safety, highlighting a growing trust in these medications as more positive outcomes are shared
GLP-1s can quiet appetite, but they dont magically protect muscle or build metabolic resilience
Reproductive Symptoms: PCOS disrupts ovulation, leading to irregular menstrual cycles, difficulty conceiving, and occasionally multiple cysts in the ovaries
Benefits of Tirzepatide Weight Loss Treatment Tirzepatide offers numerous advantages beyond weight loss numbers
Anecdotal reports of users running 6+ months show continued effectiveness without significant issues